The Trump administration has removed the two leaders of a key health advisory group that decides which preventive services, like mammograms and colonoscopies, insurance must cover for millions of Americans.
Task Force Leaders Fired
On May 11, Health Secretary Robert F. Kennedy Jr. sent letters notifying Drs. John Wong and Esa Davis that their appointments as chairs of the U.S. Preventive Services Task Force were terminated immediately, before the end of their multi-year terms. The letters praised their work and encouraged them to reapply but did not provide specific reasons for the removal.
Role of the Task Force
Created in the 1980s, the task force consists of medical experts who evaluate scientific evidence on preventive health measures, such as depression screenings and the use of statins to prevent heart attacks. It assigns letter grades to services, and under the Affordable Care Act, insurance plans must cover those rated “A” or “B” without co-pays.
Over the past year, the Department of Health and Human Services (HHS) had largely sidelined the panel, postponing public meetings indefinitely and delaying updates to guidelines on cervical cancer screening and maternal depression.
Concerns About Political Influence
Kennedy told lawmakers last month that he was reforming the task force to make it more active and transparent. Some health advocates worry this could allow less experienced political appointees to replace expert members, similar to changes made to a vaccine advisory committee.
Former task force chairman Dr. Michael Silverstein said, “This is a level of government intrusion into scientific processes that I’ve not experienced in my 10 years on the task force.” Aaron Carroll of AcademyHealth explained that staggered terms normally allow health secretaries to refresh membership without disrupting the panel’s work.
Impact on Preventive Care
The task force’s delayed updates and leadership changes have left key recommendations in limbo, affecting the timing of insurance coverage for essential preventive services. Health experts warn that this uncertainty could impact patient care and disrupt evidence-based medical guidance.
